253 related articles for article (PubMed ID: 34359785)
1. Tumor and Peripheral Immune Status in Soft Tissue Sarcoma: Implications for Immunotherapy.
Sousa LM; Almeida JS; Fortes-Andrade T; Santos-Rosa M; Freitas-Tavares P; Casanova JM; Rodrigues-Santos P
Cancers (Basel); 2021 Aug; 13(15):. PubMed ID: 34359785
[TBL] [Abstract][Full Text] [Related]
2. Immunological status of peripheral blood is associated with prognosis in patients with bone and soft-tissue sarcoma.
Kim Y; Kobayashi E; Suehara Y; Ito A; Kubota D; Tanzawa Y; Endo M; Nakatani F; Nakatsura T; Kawai A; Kaneko K; Kitano S
Oncol Lett; 2021 Mar; 21(3):212. PubMed ID: 33510813
[TBL] [Abstract][Full Text] [Related]
3. Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8
Chen H; Chen Y; Liu H; Que Y; Zhang X; Zheng F
Front Immunol; 2018; 9():1179. PubMed ID: 29896199
[TBL] [Abstract][Full Text] [Related]
4. Systemic and local immunosuppression in glioblastoma and its prognostic significance.
Stepanenko AA; Sosnovtseva AO; Valikhov MP; Chernysheva AA; Abramova OV; Pavlov KA; Chekhonin VP
Front Immunol; 2024; 15():1326753. PubMed ID: 38481999
[TBL] [Abstract][Full Text] [Related]
5. The Role of Natural Killer Cells in Soft Tissue Sarcoma: Prospects for Immunotherapy.
Fortes-Andrade T; Almeida JS; Sousa LM; Santos-Rosa M; Freitas-Tavares P; Casanova JM; Rodrigues-Santos P
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359767
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic gene modified cell based cancer vaccines.
Kozłowska A; Mackiewicz J; Mackiewicz A
Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of neutrophil-to-lymphocyte ratio and other inflammatory markers in patients with high-risk soft tissue sarcomas.
Viñal D; Martinez D; Garcia-Cuesta JA; Gutierrez-Sainz L; Martinez-Recio S; Villamayor J; Martinez-Marin V; Gallego A; Ortiz-Cruz E; Mendiola M; Pozo-Kreilinger JJ; Berjon A; Belinchon B; Bernabeu D; Espinosa E; Feliu J; Redondo A
Clin Transl Oncol; 2020 Oct; 22(10):1849-1856. PubMed ID: 32125644
[TBL] [Abstract][Full Text] [Related]
8. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
Front Immunol; 2020; 11():40. PubMed ID: 32082316
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer.
Sierzega M; Lenart M; Rutkowska M; Surman M; Mytar B; Matyja A; Siedlar M; Kulig J
Ann Surg Oncol; 2017 Mar; 24(3):808-815. PubMed ID: 27770341
[TBL] [Abstract][Full Text] [Related]
10. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
Gaggero S; Witt K; Carlsten M; Mitra S
Front Immunol; 2020; 11():621225. PubMed ID: 33584718
[TBL] [Abstract][Full Text] [Related]
11. Influence of tumor-infiltrating immune cells on local control rate, distant metastasis, and survival in patients with soft tissue sarcoma.
Smolle MA; Herbsthofer L; Goda M; Granegger B; Brcic I; Bergovec M; Scheipl S; Prietl B; El-Heliebi A; Pichler M; Gerger A; Posch F; Tomberger M; López-García P; Feichtinger J; Baumgartner C; Leithner A; Liegl-Atzwanger B; Szkandera J
Oncoimmunology; 2021 Mar; 10(1):1896658. PubMed ID: 33763294
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Estrogen in the Tumor Microenvironment.
Somasundaram A; Rothenberger NJ; Stabile LP
Adv Exp Med Biol; 2020; 1277():33-52. PubMed ID: 33119863
[TBL] [Abstract][Full Text] [Related]
13. The construction and analysis of tumor-infiltrating immune cell and ceRNA networks in recurrent soft tissue sarcoma.
Huang R; Meng T; Chen R; Yan P; Zhang J; Hu P; Zhu X; Yin H; Song D; Huang Z
Aging (Albany NY); 2019 Nov; 11(22):10116-10143. PubMed ID: 31739284
[TBL] [Abstract][Full Text] [Related]
14. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells.
Goff PH; Riolobos L; LaFleur BJ; Spraker MB; Seo YD; Smythe KS; Campbell JS; Pierce RH; Zhang Y; He Q; Kim EY; Schaub SK; Kane GM; Mantilla JG; Chen EY; Ricciotti R; Thompson MJ; Cranmer LD; Wagner MJ; Loggers ET; Jones RL; Murphy E; Blumenschein WM; McClanahan TK; Earls J; Flanagan KC; LaFranzo NA; Kim TS; Pollack SM
Clin Cancer Res; 2022 Apr; 28(8):1701-1711. PubMed ID: 35115306
[TBL] [Abstract][Full Text] [Related]
16. LAG-3 expression on tumor-infiltrating T cells in soft tissue sarcoma correlates with poor survival.
Que Y; Fang Z; Guan Y; Xiao W; Xu B; Zhao J; Chen H; Zhang X; Zeng M; Liang Y; Zhang X
Cancer Biol Med; 2019 May; 16(2):331-340. PubMed ID: 31516753
[TBL] [Abstract][Full Text] [Related]
17. Potential for immunotherapy in soft tissue sarcoma.
Tseng WW; Somaiah N; Engleman EG
Hum Vaccin Immunother; 2014; 10(11):3117-24. PubMed ID: 25625925
[TBL] [Abstract][Full Text] [Related]
18. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.
Cekic C; Day YJ; Sag D; Linden J
Cancer Res; 2014 Dec; 74(24):7250-9. PubMed ID: 25377469
[TBL] [Abstract][Full Text] [Related]
19. The Potential of Five Immune-Related Prognostic Genes to Predict Survival and Response to Immune Checkpoint Inhibitors for Soft Tissue Sarcomas Based on Multi-Omic Study.
Gu HY; Lin LL; Zhang C; Yang M; Zhong HC; Wei RX
Front Oncol; 2020; 10():1317. PubMed ID: 32850416
[TBL] [Abstract][Full Text] [Related]
20. Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers.
Fujimura T; Aiba S
Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32707850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
